Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases

Scandinavian Journal of Infectious Diseases
Dino SgarabottoPaolo Cadrobbi

Abstract

Synercid (quinupristin/dalfopristin), the first semi-synthetic injectable streptogramin, is a promising alternative to glycopeptides against many Gram-positive multiresistant bacteria. Vancomycin is still considered an effective agent for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections but therapeutic failures with glycopeptides have been observed, even for the treatment of infections caused by S. aureus strains sensitive to vancomycin. Synercid, in combination with a glycopeptide, may address this problem without causing significant side effects due to the different toxicity patterns of the 2 antimicrobials. This study reports our experience with the combination of Synercid and vancomycin in 5 patients with severe infection caused by MRSA or methicillin-resistant coagulase-negative Staphylococcus.

References

Jan 1, 1996·Drugs·E Rubinstein, N Keller
Jan 15, 2000·Lancet·A P Johnson, D M Livermore
Dec 29, 2000·Pharmacotherapy·G DelgadoL H Danziger

❮ Previous
Next ❯

Citations

Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George M Eliopoulos
Mar 4, 2009·Enfermedades infecciosas y microbiología clínica·Francisco GudiolUNKNOWN Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Oct 13, 2007·Expert Opinion on Pharmacotherapy·Evelina Tacconelli, Maria A Cataldo
Sep 17, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Evangelo BoumisUNKNOWN GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) Working Group on Bloodstream Infections and Endocarditis
Apr 9, 2008·Annales de cardiologie et d'angéiologie·A Makinson, V Le Moing
Mar 3, 2004·The Annals of Pharmacotherapy·Jack Brown, Burgess B Freeman
Jun 21, 2005·Current Infectious Disease Reports·Jennifer K Long

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.